Follow this preprint

Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma

Seunghun Han, Sabrina Y. Camp, Hoyin Chu, Ryan Collins, Riaz Gillani, Jihye Park, Ziad Bakouny, Cora A. Ricker, Brendan Reardon, Nicholas Moore, Eric Kofman, Chris Labaki, David Braun, Toni K. Choueiri, Saud H. AlDubayan, Eliezer M. Van Allen
doi: https://doi.org/10.1101/2023.01.18.23284664

Article Information

doi 
https://doi.org/10.1101/2023.01.18.23284664
History 
  • January 19, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Seunghun Han1,2,3,
  2. Sabrina Y. Camp2,3,
  3. Hoyin Chu2,3,
  4. Ryan Collins2,3,4,
  5. Riaz Gillani3,5,6,7,
  6. Jihye Park2,3,
  7. Ziad Bakouny2,3,
  8. Cora A. Ricker2,3,
  9. Brendan Reardon2,3,
  10. Nicholas Moore8,
  11. Eric Kofman9,
  12. Chris Labaki2,
  13. David Braun10,
  14. Toni K. Choueiri11,12,
  15. Saud H. AlDubayan2,3,13,14,^,* and
  16. Eliezer M. Van Allen2,3,15,^,*
  1. 1Ph.D. Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA
  2. 2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
  3. 3Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA
  4. 4Department of Medicine, Harvard Medical School, Boston, MA, USA
  5. 5Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  6. 6Department of Pediatrics, Harvard Medical School, Boston, MA, USA
  7. 7Boston Children’s Hospital, Boston, MA, USA
  8. 8Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
  9. 9Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA
  10. 10Center of Molecular and Cellular Oncology, Yale School of Medicine, New Haven, CT, USA
  11. 11Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
  12. 12Brigham and Women’s Hospital, Boston, MA, USA
  13. 13Division of Genetics, Brigham and Women’s Hospital, Boston, MA, USA
  14. 14College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  15. 15Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA
  1. ↵*Corresponding Authors:
    1- Eliezer Van Allen, MD (EliezerM_VanAllen{at}dfci.harvard.edu), Dana-Farber Cancer Institute, 450 Brookline Ave, LC, 2- Saud H. AlDubayan, MD (Saud_Aldubayan{at}dfci.harvard.edu), Dana-Farber Cancer Institute, 41 Avenue Louis Pasteur, Suite 303-01, Boston, MA, 02215, Tel. 617-515-5776
Back to top
Posted January 19, 2023.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma
Seunghun Han, Sabrina Y. Camp, Hoyin Chu, Ryan Collins, Riaz Gillani, Jihye Park, Ziad Bakouny, Cora A. Ricker, Brendan Reardon, Nicholas Moore, Eric Kofman, Chris Labaki, David Braun, Toni K. Choueiri, Saud H. AlDubayan, Eliezer M. Van Allen
medRxiv 2023.01.18.23284664; doi: https://doi.org/10.1101/2023.01.18.23284664
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.